Challenger Ltd

CGF: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.@LkLOCK|!<LOCK|Y<%Pp&%

Challenger Earnings: Undervalued as Market Likely Expects Excessive Deterioration

Challenger's normalized NPAT for first half fiscal 2025 grew by 12% from first half fiscal 2024. However, shares still declined intraday.

Sponsor Center